Sebastiaan Remmers

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC).

Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC).

Journal: BJU international

Published: July 04, 2026

Prostate Cancer Mortality in Men not Attending a Population-based Screening Program: The 'Good', the 'Bad', and the 'Ugly' After 20-yr Follow-up in the European Randomised study of Screening for Prostate Cancer.

Prostate Cancer Mortality in Men not Attending a Population-based Screening Program: The 'Good', the 'Bad', and the 'Ugly' After 20-yr Follow-up in the European Randomised study of Screening for Prostate Cancer.

Journal: European urology open science

Published: June 14, 2026

The Prognostic Value of Baseline PSA Density on Long-term Oncological Outcomes in Men with an Initial Negative Prostate Biopsy: Results from ERSPC Rotterdam.

The Prognostic Value of Baseline PSA Density on Long-term Oncological Outcomes in Men with an Initial Negative Prostate Biopsy: Results from ERSPC Rotterdam.

Journal: European urology open science

Published: June 10, 2026

Who, When, and How: Watchful Waiting in the ERSPC Rotterdam.

Who, When, and How: Watchful Waiting in the ERSPC Rotterdam.

Journal: European urology open science

Published: March 12, 2026

Prostate cancer mortality among men with and without comorbidity: Long-term results from the European randomized study of screening for prostate cancer Rotterdam.

Prostate cancer mortality among men with and without comorbidity: Long-term results from the European randomized study of screening for prostate cancer Rotterdam.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 30, 2026

Treatment-Free Survival and the Pattern of Follow-Up Treatments After Curative Prostate Cancer Treatment, a Real-World Analysis of Big Data from Electronic Health Records from a Tertiary Center.

Treatment-Free Survival and the Pattern of Follow-Up Treatments After Curative Prostate Cancer Treatment, a Real-World Analysis of Big Data from Electronic Health Records from a Tertiary Center.

Journal: Journal of personalized medicine

Published: November 30, 2025

European Study of Prostate Cancer Screening - 23-Year Follow-up.

European Study of Prostate Cancer Screening - 23-Year Follow-up.

Journal: The New England journal of medicine

Published: October 29, 2025

Effects of Causal and Noncausal Components of Screening on Prostate Cancer Mortality: A Mediation Analysis from the Dutch, Finnish, and Swedish Centers of the European Randomized Study of Screening for Prostate Cancer.

Effects of Causal and Noncausal Components of Screening on Prostate Cancer Mortality: A Mediation Analysis from the Dutch, Finnish, and Swedish Centers of the European Randomized Study of Screening for Prostate Cancer.

Journal: European urology oncology

Published: September 29, 2025

Real-world Evidence on Baseline Characteristics and Treatment in Metastatic Hormone-sensitive Prostate Cancer: Findings from the PIONEER 2.0 Big Data Investigation Group.

Real-world Evidence on Baseline Characteristics and Treatment in Metastatic Hormone-sensitive Prostate Cancer: Findings from the PIONEER 2.0 Big Data Investigation Group.

Journal: European urology open science

Published: September 19, 2025

Extending Current Guideline-recommended Prostate-specific Antigen Density Thresholds for Improving Benefit/Harm Balance in Risk-based Magnetic Resonance Imaging-directed Prostate Cancer Diagnosis, from the Community-based Multicentre MR-PROPER Study.

Extending Current Guideline-recommended Prostate-specific Antigen Density Thresholds for Improving Benefit/Harm Balance in Risk-based Magnetic Resonance Imaging-directed Prostate Cancer Diagnosis, from the Community-based Multicentre MR-PROPER Study.

Journal: European urology oncology

Published: August 28, 2025

Rethinking Gleason pattern quantification in predicting metastasis: results of 20 years of follow-up in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.

Rethinking Gleason pattern quantification in predicting metastasis: results of 20 years of follow-up in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.

Journal: Histopathology

Published: June 12, 2025

Experience of 5 years adjustable continence therapy (ProACT): the surgical learning curve and patient outcomes.

Experience of 5 years adjustable continence therapy (ProACT): the surgical learning curve and patient outcomes.

Journal: World journal of urology

Published: June 04, 2025

Showing 1-12 of 102

Last Updated: 09/26/2026